Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Dario Bruzzese is active.

Publication


Featured researches published by Dario Bruzzese.


Clinical Nutrition | 2009

A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: an observational study.

Eugenia Bruzzese; Monica Volpicelli; Veronica Squeglia; Dario Bruzzese; Filippo Salvini; Massimo Bisceglia; Paolo Lionetti; Mario Cinquetti; Giuseppe Iacono; Sergio Amarri; Alfredo Guarino

BACKGROUND & AIM The addition of prebiotics to infant formula modifies the composition of intestinal microflora. Aim of the study was to test the hypothesis that prebiotics reduce the incidence of intestinal and respiratory infections in healthy infants. METHODS A prospective, randomized, placebo-controlled, open trial was performed. Healthy infants were enrolled and randomized to a formula additioned with a mixture of galacto- and fructo-oligosaccharides or to a control formula. The incidence of intestinal and respiratory tract infections and the anthropometric measures were monitored for 12 months. RESULTS Three hundred and forty two infants (mean age 53.7+/-32.1 days) were enrolled. The incidence of gastroenteritis was lower in the supplemented group than in the controls (0.12+/-0.04 vs. 0.29+/-0.05 episodes/child/12 months; p=0.015). The number of children with more than 3 episodes tended to be lower in prebiotic group (17/60 vs. 29/65; p=0.06). The number of children with multiple antibiotic courses/year was lower in children receiving prebiotics (24/60 vs. 43/65; p=0.004). A transient increase in body weight was observed in children on prebiotics compared to controls during the first 6 months of follow-up. CONCLUSIONS Prebiotic administration reduce intestinal and, possibly, respiratory infections in healthy infants during the first year of age.


Nature Medicine | 2014

Regulatory T cell proliferative potential is impaired in human autoimmune disease

Fortunata Carbone; Veronica De Rosa; P. B. Carrieri; Silvana Montella; Dario Bruzzese; Antonio Porcellini; Claudio Procaccini; Antonio La Cava; Giuseppe Matarese

Human CD4+CD25highCD127−FoxP3+ regulatory T (Treg) cells suppress immune responses in vitro and in vivo. Reduced suppressive function and/or number of peripheral Treg cells has been previously reported in autoimmune disorders. Treg cells represent the most actively replicating compartment within the CD4+ cells in vivo, but they are hyporesponsive to classical T cell receptor (TCR) stimulation in vitro, a condition that is secondary to their overactive metabolic state. Here we report that proliferation of Treg cells after TCR stimulation is impaired in subjects with relapsing-remitting multiple sclerosis (RRMS) because of altered interleukin-2 (IL-2) secretion and IL-2 receptor (IL-2R)–signal transducer and activator of transcription 5 (STAT5) signaling. This is associated with decreased expression of the forkhead box P3 (FoxP3) 44- and 47-kDa splicing forms, overactivation of S6 ribosomal protein (a downstream target of the mammalian target of rapamycin, mTOR) and altered activity of the cyclin-dependent kinase inhibitor p27 (p27kip1) and extracellular signal–related kinases 1 and 2 (ERK1/2). The impaired capacity of Treg cells to proliferate in RRMS correlates with the clinical state of the subject, where increasing disease severity is associated with a decline in Treg cell expansion. These results suggest a previously unrecognized mechanism that may account for the progressive loss of Treg cells in autoimmune disease.


PLOS ONE | 2013

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml

Matteo Ferro; Dario Bruzzese; Sisto Perdonà; Ada Marino; Claudia Mazzarella; Giuseppe Perruolo; Vittoria D’Esposito; Vincenzo Cosimato; Carlo Buonerba; Giuseppe Di Lorenzo; Gennaro Musi; Ottavio De Cobelli; Felix K.-H. Chun; Daniela Terracciano

Many efforts to reduce prostate specific antigen (PSA) overdiagnosis and overtreatment have been made. To this aim, Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) have been proposed as new more specific biomarkers. We evaluated the ability of phi and PCA3 to identify prostate cancer (PCa) at initial prostate biopsy in men with total PSA range of 2–10 ng/ml. The performance of phi and PCA3 were evaluated in 300 patients undergoing first prostate biopsy. ROC curve analyses tested the accuracy (AUC) of phi and PCA3 in predicting PCa. Decision curve analyses (DCA) were used to compare the clinical benefit of the two biomarkers. We found that the AUC value of phi (0.77) was comparable to those of %p2PSA (0.76) and PCA3 (0.73) with no significant differences in pairwise comparison (%p2PSA vs phi p = 0.673, %p2PSA vs. PCA3 p = 0.417 and phi vs. PCA3 p = 0.247). These three biomarkers significantly outperformed fPSA (AUC = 0.60), % fPSA (AUC = 0.62) and p2PSA (AUC = 0.63). At DCA, phi and PCA3 exhibited a very close net benefit profile until the threshold probability of 25%, then phi index showed higher net benefit than PCA3. Multivariable analysis showed that the addition of phi and PCA3 to the base multivariable model (age, PSA, %fPSA, DRE, prostate volume) increased predictive accuracy, whereas no model improved single biomarker performance. Finally we showed that subjects with active surveillance (AS) compatible cancer had significantly lower phi and PCA3 values (p<0.001 and p = 0.01, respectively). In conclusion, both phi and PCA3 comparably increase the accuracy in predicting the presence of PCa in total PSA range 2–10 ng/ml at initial biopsy, outperforming currently used %fPSA.


European Journal of Endocrinology | 2011

Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism

Manuela Cerbone; Carmela Bravaccio; Donatella Capalbo; Miriam Polizzi; Malgorazata Wasniewska; Daniela Cioffi; Nicola Improda; Mariella Valenzise; Dario Bruzzese; Filippo De Luca; Mariacarolina Salerno

OBJECTIVE The treatment of children with subclinical hypothyroidism (SH) is controversial for TSH values between 4.5 and 10 mU/l. The aim of this cross-sectional, controlled study was to evaluate growth and intellectual outcome in children with persistent SH who have never been treated with levothyroxine. DESIGN AND METHODS Clinical and auxological parameters, thyroid function, and intellectual outcome were evaluated in 36 children with persistent SH at the age of 9.7±0.6 (range 4-18.0) years. Children had been followed longitudinally for 3.3±0.3 (range 2.0-9.3) years, from first diagnosis of SH until enrollment in the study. Thirty-six age- and sex-matched children were enrolled in the study as controls. RESULTS At study entry, height (-0.8±0.2 SDS), bone age/chronological age (BA/CA ratio 0.92±0.6), and body mass index (BMI -0.1±0.2 SDS) in SH children were normal. Despite long-term duration of SH, none of these parameters showed a worsening with respect to height (-0.7±0.2 SDS), BA/CA (0.97±0.03), and BMI (-0.1±0.2) at the time of first SH detection. None of the children showed overt signs or symptoms of hypothyroidism during the follow-up. Verbal (99.1±2.2), performance (100.4±1.9), and full-scale (99.7±1.9) intelligence quotient (IQ) scores in SH children were normal and comparable to those of controls. No relationship was detected between IQ scores and the degree or duration of SH. CONCLUSIONS Persistent SH in children is not associated with alterations in growth, bone maturation, BMI, and cognitive function or other complaints that could be ascribed to SH even after several years without therapeutic intervention.


Respirology | 2012

Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease

Silvia Montella; Marco Maglione; Dario Bruzzese; Carmine Mollica; Claudio Pignata; Giuseppina Aloj; Angelo Manna; Antonietta Esposito; Virginia Mirra; Francesca Santamaria

Background and objective:  Chest MRI is increasingly used to assess pulmonary diseases, but its utility compared with high‐resolution computed tomography (HRCT) has never been evaluated in children using specific performance outcomes. The aim of this study was to assess the accuracy and reliability of MRI compared with HRCT in children with non‐cystic fibrosis (CF) chronic lung disease.


Clinica Chimica Acta | 2012

Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers.

Matteo Ferro; Dario Bruzzese; Sisto Perdonà; Claudia Mazzarella; Ada Marino; Alessandra Sorrentino; Angelina Di Carlo; Riccardo Autorino; Giuseppe Di Lorenzo; Carlo Buonerba; Vincenzo Altieri; Angela Mariano; Vincenzo Macchia; Daniela Terracciano

Indication for prostate biopsy is presently mainly based on prostate-specific antigen (PSA) serum levels and digital-rectal examination (DRE). In view of the unsatisfactory accuracy of these two diagnostic exams, research has focused on novel markers to improve pre-biopsy prostate cancer detection, such as phi and PCA3. The purpose of this prospective study was to assess the diagnostic accuracy of phi and PCA3 for prostate cancer using biopsy as gold standard. Phi index (Beckman coulter immunoassay), PCA3 score (Progensa PCA3 assay) and other established biomarkers (tPSA, fPSA and %fPSA) were assessed before a 18-core prostate biopsy in a group of 251 subjects at their first biopsy. Values of %p2PSA and phi were significantly higher in patients with PCa compared with PCa-negative group (p<0.001) and also compared with high grade prostatic intraepithelial neoplasia (HGPIN) (p<0.001). PCA3 score values were significantly higher in PCa compared with PCa-negative subjects (p<0.001) and in HGPIN vs PCa-negative patients (p<0.001). ROC curve analysis showed that %p2PSA, phi and PCA3 are predictive of malignancy. In conclusion, %p2PSA, phi and PCA3 may predict a diagnosis of PCa in men undergoing their first prostate biopsy. PCA3 score is more useful in discriminating between HGPIN and non-cancer.


The Prostate | 2013

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy.

Sisto Perdonà; Dario Bruzzese; Matteo Ferro; Riccardo Autorino; Ada Marino; Claudia Mazzarella; Giuseppe Perruolo; Michele Longo; Rosa Spinelli; Giuseppe Di Lorenzo; Andrea Oliva; Marco De Sio; Rocco Damiano; Vincenzo Altieri; Daniela Terracciano

Prostate health index (phi) and prostate cancer antigen 3 (PCA3) have been recently proposed as novel biomarkers for prostate cancer (PCa). We assessed the diagnostic performance of these biomarkers, alone or in combination, in men undergoing first prostate biopsy for suspicion of PCa.


Clinical Endocrinology | 2014

Cluster of cardiometabolic risk factors in children with GH deficiency: a prospective, case–control study

Donatella Capalbo; Giuseppina Mattace Raso; Andrea Esposito; Raffaella Di Mase; Flavia Barbieri; Rosaria Meli; Dario Bruzzese; Mariacarolina Salerno

Growth hormone (GH) deficiency (GHD) in adults is associated with increased cardiovascular (CV) risk. Although some authors have documented the presence of early CV risk factors in untreated GHD children, results are still inconsistent. Aim of this study was to evaluate the effects of GHD and GH therapy on early cardiometabolic risk factors in a large cohort of children.


Oncotarget | 2016

Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis.

Michele Olivieri; Matteo Ferro; Sara Terreri; Montano Durso; Alessandra Romanelli; Concetta Avitabile; Ottavio De Cobelli; Anna Messere; Dario Bruzzese; Ivan Vannini; Luciana Marinelli; Ettore Novellino; Wei Zhang; Mariarosaria Incoronato; Gennaro Ilardi; Stefania Staibano; Laura Marra; Renato Franco; Sisto Perdonà; Daniela Terracciano; Bogdan Czerniak; Giovanna L. Liguori; Vincenza Colonna; Muller Fabbri; Ferdinando Febbraio; George A. Calin; Amelia Cimmino

Ultraconserved regions (UCRs) have been shown to originate non-coding RNA transcripts (T-UCRs) that have different expression profiles and play functional roles in the pathophysiology of multiple cancers. The relevance of these functions to the pathogenesis of bladder cancer (BlCa) is speculative. To elucidate this relevance, we first used genome-wide profiling to evaluate the expression of T-UCRs in BlCa tissues. Analysis of two datasets comprising normal bladder tissues and BlCa specimens with a custom T-UCR microarray identified ultraconserved RNA (uc.) 8+ as the most upregulated T-UCR in BlCa tissues, although its expression was lower than in pericancerous bladder tissues. These results were confirmed on BlCa tissues by real-time PCR and by in situ hybridization. Although uc.8+ is located within intron 1 of CASZ1, a zinc-finger transcription factor, the transcribed non-coding RNA encoding uc.8+ is expressed independently of CASZ1. In vitro experiments evaluating the effects of uc.8+ silencing, showed significantly decreased capacities for cancer cell invasion, migration, and proliferation. From this, we proposed and validated a model of interaction in which uc.8+ shuttles from the nucleus to the cytoplasm of BlCa cells, interacts with microRNA (miR)-596, and cooperates in the promotion and development of BlCa. Using computational analysis, we investigated the miR-binding domain accessibility, as determined by base-pairing interactions within the uc.8+ predicted secondary structure, RNA binding affinity, and RNA species abundance in bladder tissues and showed that uc.8+ is a natural decoy for miR-596. Thus uc.8+ upregulation results in increased expression of MMP9, increasing the invasive potential of BlCa cells. These interactions between evolutionarily conserved regions of DNA suggest that natural selection has preserved this potentially regulatory layer that uses RNA to modulate miR levels, opening up the possibility for development of useful markers for early diagnosis and prognosis as well as for development of new RNA-based cancer therapies.


Visual Data Mining | 2008

Visual Mining of Association Rules

Dario Bruzzese; Cristina Davino

Association Rules are one of the most widespread data mining tools because they can be easily mined, even from very huge database, and they provide valuable information for many application fields such as marketing, credit scoring, business, etc. The counterpart is that a massive effort is required (due to the large number of rules usually mined) in order to make actionable the retained knowledge. In this framework vizualization tools become essential to have a deep insight into the association structures and interactive features have to be exploited for highlighting the most relevant and meaningful rules.

Collaboration


Dive into the Dario Bruzzese's collaboration.

Top Co-Authors

Avatar

Daniela Terracciano

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Enrica Menditto

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Matteo Ferro

European Institute of Oncology

View shared research outputs
Top Co-Authors

Avatar

Sabino De Placido

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Giuseppe Di Lorenzo

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Giuseppe Matarese

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Sisto Perdonà

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Alessandro Sanduzzi

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Alfredo Guarino

University of Naples Federico II

View shared research outputs
Top Co-Authors

Avatar

Claudia Mazzarella

University of Naples Federico II

View shared research outputs
Researchain Logo
Decentralizing Knowledge